bioRxiv ScienceSearch

bioRxiv · 10.1101/180927

Sensitivity analysis based ranking reveals unknown biological hypotheses for down regulated genes in time buffer during administration of PORCN-WNT inhibitor ETC-1922159 in CRC

Abstract

In a recent development of the PORCN-WNT inhibitor ETC-1922159 for colorectal cancer, a list of down-regulated genes were recorded in a time buffer after the administration of the drug. The regulation of the genes were recorded individually but it is still not known which higher ([≥] 2) order interactions might be playing a greater role after the administration of the drug. In order to reveal the priority of these higher order interactions among the down-regulated genes or the likely unknown biological hypotheses, a search engine was developed based on the sensitivity indices of the higher order interactions that were ranked using a support vector ranking algorithm and sorted. For example, LGR family (Wnt signal enhancer) is known to neutralize RNF43 (Wnt inhibitor). After the administration of ETC-1922159 it was found that using HSIC (and rbf, linear and laplace variants of kernel) the rankings of the interaction between LGR5-RNF43 were 61, 114 and 85 respectively. Rankings for LGR6-RNF43 were 1652, 939 and 805 respectively. The down-regulation of LGR family after the drug treatment is evident in these rankings as it takes bottom priorities for LGR5-RNF43 interaction. The LGR6-RNF43 takes higher ranking than LGR5-RNF43, indicating that it might not be playing a greater role as LGR5 during the Wnt enhancing signals. These rankings confirm the efficacy of the proposed search engine design. Conclusion: Prioritized unknown biological hypothesis form the basis of further wet lab tests with the aim to reduce the cost of (1) wet lab experiments (2) combinatorial search and (3) lower the testing time for biologist who search for influential interactions in a vast combinatorial search forest. From in silico perspective, a framework for a search engine now exists which can generate rankings for nth order interactions in Wnt signaling pathway, thus revealing unknown/untested/unexplored biological hypotheses and aiding in understanding the mechanism of the pathway. The generic nature of the design can be applied to any signaling pathway or phenomena under investigation where a prioritized order of interactions among the involved factors need to be investigated for deeper understanding. Future improvements of the design are bound to facilitate medical specialists/oncologists in their respective investigations.\n\nSignificanceRecent development of PORCN-WNT inhibitor enantiomer ETC-1922159 cancer drug show promise in suppressing some types of colorectal cancer. However, the search and wet lab testing of unknown/unexplored/untested biological hypotheses in the form of combinations of various intra/ extracellular factors/genes/proteins affected by ETC-1922159 is not known. Currently, a major problem in biology is to cherry pick the combinations based on expert advice, literature survey or guesses to investigate a particular combinatorial hypothesis. A search engine has be developed to reveal and prioritise these unknown/untested/unexplored combinations affected by the inhibitor. These ranked unknown biological hypotheses facilitate in narrowing down the investigation in a vast combinatorial search forest of ETC-1922159 affected synergistic-factors.

Explore related subjects

Keep this discovery

BibTeXRIS

Sinha, S.. 2017-08-26. Sensitivity analysis based ranking reveals unknown biological hypotheses for down regulated genes in time buffer during administration of PORCN-WNT inhibitor ETC-1922159 in CRC. https://doi.org/10.1101/180927

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Ex vivo human tumor slices more accurately predict patient responses to an oncolytic virus than in vivo mouse models

Immunotherapies, including oncolytic viruses (OV), are promising therapies that can enhance anti-tumor immune responses. However, preclinical success of immunotherapies in mouse models has not always translated to clinical benefit in cancer patients. This study compared preclinical efficacy and mechanism of action for ASP9801, a vaccinia virus expressing IL-7 and IL-12, using mouse models of colorectal cancer (CRC) in vivo and in human organotypic tumor slice models ex vivo. The murine surrogate for ASP9801 significantly reduced tumor volumes in treated and abscopal tumors in two different CRC models in vivo (MC38 and RO100). Treatment efficacy was accentuated when combined with anti-PD1 treatment, and single-cell RNA sequencing analysis revealed depletion of tumor cells and increased T cell infiltration and activation in both treated and abscopal tumors. However, human tissue analysis ex vivo (E-slices) using PDX models and patient samples showed that ASP9801 is not effective in CRC, consistent with clinical trial results. On the other hand, ASP9801 was highly effective in GBM, indicating indication-specific efficacy of ASP9801, and how E-slice assays can be used to identify treatment-sensitive indications. This study demonstrates the superiority of E-slices over mouse models for predicting clinical response and its utility in planning clinical trials.

cancer biology

Immune-cell depleted diffuse large B-cell lymphomas have reduced expression of MHC class I

Immunotherapy has transformed treatment for many cancers. In the aggressive and genetically heterogeneous diffuse large B-cell lymphoma (DLBCL), CD19 CAR T-cell therapy is highly effective, whereas immune checkpoint blockade has shown limited benefit. Loss of MHC expression is a common mechanism to escape T-cell cytotoxicity, and loss of MHC class I (MHC-I) and II are frequent in DLBCL. We applied imaging mass cytometry to diagnostic biopsies from younger, high-risk DLBCL patients to map the tumor microenvironment (TME) spatial architecture in relation to tumor cell MHC expression, mutational status, transcriptomic and proteomic profiles. Neighborhood analyses identified four TME subtypes: immune-cell depleted and three immune-infiltrated types (mixed, CD4 T cell-rich, CD8 T-cell/macrophage-rich). Depleted cases had shorter overall survival (p = 0.033) and increased expression of proteins involved in DNA replication and proliferation markers compared to infiltrated cases. Tumor cell MHC-I expression was heterogeneous. Cases with low frequency of MHC-I-pos tumor cells were enriched for the depleted TME type. MHC-I-pos tumor cells were surrounded by CD4 and CD8 T cells and M1 macrophages, whereas MHC-I-neg tumor cells were closer to other MHC-I-neg tumor cells. These findings suggest that TME-based classification incorporating tumor cell MHC-I status may improve individualized immunotherapy selection.

cancer biology

Cross-species analysis links cell-cell communication rewiring to NOTCH2 during serous endometrial carcinogenesis

Cell-cell interactions shape the fate of mutant cells during cancer initiation but how these interactions evolve during progression to pathologically recognizable lesions remain poorly understood. Here, we investigated cell-cell communication during serous endometrial carcinoma (SEC; also known as uterine serous carcinoma) development using a lineage-traceable mouse model and cross-species analyses of the mouse and human neoplastic endometrium. In mice, the early, pre-dysplastic stage was marked by a global decrease in inferred cell-cell interactions, followed by extensive communication network rewiring during neoplastic progression. Pathway-specific analysis revealed a similar pattern for NOTCH signaling, with NOTCH2 emerging as the dominant NOTCH receptor in Trp53/Rb1-mutant immature epithelial cells. Functionally, NOTCH2 promoted the outgrowth of more proliferative mutant organoids. Cross-species transcriptomic analysis identified conserved immature epithelial states in mouse and human neoplastic endometrial epithelium. In human tissues, NOTCH2 was overexpressed in serous endometrial intraepithelial carcinoma, a precursor of SEC, and in overt SEC. Furthermore, elevated NOTCH2 expression was associated with poor patient survival. These findings link cell-cell communication rewiring during experimental SEC development to conserved neoplastic epithelial states and identify NOTCH2 as an early marker and a potential target of disease interception.

cancer biology